Xmax Inc. 8-K Filing Summary
Business Context and Reporting Period
Xmax Inc., a Nevada corporation, filed this Current Report on Form 8-K on July 24, 2026. The filing details the results of a special meeting of stockholders held on the same date to approve significant equity issuance proposals.
Key Financial Metrics
This filing is a corporate governance report regarding shareholder votes and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Shareholders approved three key proposals at the special meeting:
- Proposal 1 (Private Placement Issuance): Approved the sale and issuance of more than 20% of outstanding common stock in a private placement at a price below the Nasdaq "Minimum Price."
- Proposal 2 (Shelf Issuance): Approved the sale and issuance of more than 20% of outstanding common stock in a registered direct offering under Form S-3 at a price below the Nasdaq "Minimum Price."
- Proposal 3 (Discretionary Authority): Granted the Chairman of the Board authority to adjourn the meeting to solicit additional proxies if necessary.
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Private Placement Issuance | 25,775,447 | 279,140 | 52,402 |
| Shelf Issuance | 25,775,415 | 279,146 | 52,428 |
| Discretionary Authority | 25,775,196 | 279,478 | 52,315 |
Outlook, Risks, and Management Commentary
The approval of these proposals enables the Company to raise capital through significant equity dilution at prices below the standard Nasdaq listing thresholds. The filing does not provide specific guidance, management commentary on future operations, or detailed risk factors beyond the implications of the approved issuances.
Key Facts for Investor Verification
- Verify the specific pricing and total capital raised in the approved Private Placement and Shelf Issuance.
- Assess the immediate dilution impact on existing shareholders given the issuance of over 20% of outstanding stock.
- Review the effective Form S-3 (Registration Number 333-295406) for details on the Shelf Issuance terms.
- Monitor subsequent filings for the execution timeline of these capital raises.